SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?


To: Decci who wrote (9047)4/24/1998 1:26:00 AM
From: R. Gates  Read Replies (1) | Respond to of 14328
 
A drift down on light volume makes Thursday a non-event. We should have a support level here, or just slightly lower, but I doubt we'll see $2 again. I see the BIG WEEK, starting next week.

Happy Investing!

R. Gates



To: Decci who wrote (9047)4/24/1998 2:47:00 AM
From: milton  Respond to of 14328
 
Decci:
Noted that other lesser stocks sell at greater multiples, especially in the biotech area. I note that these other stocks generally have sought out and gotten analyst interest, a key issue if a company wants to attract investor interest and obtain market recognition of value. But note that triby has no history of going after analysts. I never see any analysts reports on triby. This thread is the only public recognition of triby's value. I've determined that this is a result of triby's management which has been rightly focused on building a solid and growing company. But it seems time that management went to the market and sought analyst interest. The result would be a better valuation of triby and more access to capital markets, an important concept to a growing company like triby. Meanwhile, us threaders have to suffer in silence knowing that it's inevitable that this stock will finally find its day in the sun. At that point, this stock is going to really take off and quickly. Long on triby.